Proteomics Market Worth $70.56 Billion by 2030 at CAGR 13.5%: Grand View Research, Inc.

News provided by

Jul 27, 2022, 09:30 ET

SAN FRANCISCO, July 27, 2022 /PRNewswire/ -- The global proteomics market size is expected to reach USD 70.56 billion by 2030, registering a CAGR of 13.5% over the forecast period, according to a new report by Grand View Research, Inc. The major factors driving the industry growth are a rise in the demand for personalized medicine, an expansion of the pipeline of diagnostics utilizing proteomics mass spectrometry as well as biochip platforms, and discoveries based on genomics. Moreover, owing to the importance of proteomics in drug development, numerous pharmaceutical companies have established their own proteomic divisions, which are fueling the expansion of the global industry. For instance, in September 2021, Biognosys, announced the collaboration with Evotec, to promote the use of next-generation proteomics in clinical research and drug discovery.

Key Insights & Findings from the report:

The reagent & consumables product segment held the largest share in 2021 due to rising research activities and the growing demand for protein separation from complicated mixtures for efficient analysis.
The clinical diagnostics application segment held a larger share in 2021 due to the development of sophisticated & specialized tests for early disease detection and disease management.
The spectroscopy technology segment held the maximum share in 2021 owing to the increasing usage in toxicological response profiling, basic molecular biology, biomarker identification, and pharmaceutical target screening.
North America led the global industry in 2021 due to a rise in demand for personalized drugs, the existence of major players operating in the U.S. and a highly developed healthcare research framework, and substantial expenditure on R&D.
Asia Pacific is expected to grow at the highest CAGR over the projected period due to factors, such as the rising prevalence of target diseases, increasing aging population, and rising proteomics adoption.

Read 175-page full market research report, "Proteomics Market Size, Share & Trends Analysis Report By Product (Services, Reagents & Consumables, Instruments), By Technology (Spectroscopy, Microarray), By Application, And Segment Forecasts, 2022 - 2030", published by Grand View Research.

Proteomics Market Growth & Trends

The COVID-19 outbreak is expected to have a significant impact on the industry, as researchers across the world are concentrating on decoding 3D structures of SARS-CoV-2 proteins. To create effective medications and biological products against COVID-19, scientists are also attempting to examine the identification techniques, structures, characterization, and interactions of these proteins. The protein structure of virus proteins and their specific locations must be understood to find a novel, efficient target treatment medication for a virus. Therefore, it will increase the demand for drug development for COVID-19 and propel industry growth. The growing need for customized medications increased R&D spending, and technological developments related to proteomics components are also driving the market.

In addition, attractive market expansion potential for proteomics is anticipated to come from improvements in mass spectrometry-based proteomics and lucrative opportunities related to biomarker identification. Thereby, propelling the market growth. The introduction of new and improved proteomics techniques by major industry participants is projected to further accelerate the growth of the industry. For instance, to provide quick data acquisition for shotgun proteomics, Bruker Corp. introduced the tipstaff Pro system for Parallel Accumulation and Serial Fragmentation (PASEF) mass spectrometry in September 2017. This system uses proprietary Trapped Ion Mobility Spectrometry (TIMS) technology. Furthermore, proteomic research advancements have accelerated the detection of protein biomarkers, protein biochips & pharmacoproteomics, and proteomics-based molecular diagnostics, which have all made significant contributions to the development of personalized medicine

Proteomics Market Segmentation

Grand View Research has segmented the global proteomics market based on product, application, technology, and region:

Proteomics Market - Product Scope Outlook (Revenue, USD Million, 2018 - 2030)

Instruments
Reagents & Consumables
Services

Proteomics Market - Application Scope Outlook (Revenue, USD Million, 2018 - 2030)

Drug Discovery
Clinical Diagnostics
Others

Proteomics Market - Technology Outlook (Revenue, USD Million, 2018 - 2030)

Microarray Instruments
X-Ray Crystallography
Spectroscopy
Chromatography
Protein Fractionation Systems
Electrophoresis
Surface Plasma Resonance (SPR) Systems

Proteomics Market - Regional Scope Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.
Canada

Europe

U.K.
Germany

Asia Pacific

Japan
China

Latin America

Brazil

Middle East & Africa

South Africa

List of Key Players of Proteomics Market

Illumina, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
GE Healthcare
Thermo Fisher Scientific, Inc.
Bruker Corporation
F. Hoffmann-La Roche Ltd.
Promega Corp.
Merck KGaA.
Danaher

Check out more related studies published by Grand View Research:

Cancer/Tumor Profiling Market - The global cancer/tumor profiling market size is expected to reach USD 21.08 billion by 2025, exhibiting a CAGR of 8.8%, according to a new report by Grand View Research, Inc. Rising research in the application of omics sciences in cancer detection is anticipated to influence market growth.
Cancer Biomarkers Market - The global cancer biomarkers market size is expected to reach a value of USD 33.7 billion by 2025, at a CAGR of 14.3% based on a new report by Grand View Research, Inc. Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the introduction of technologically advanced companion diagnostic kits is estimated to provide the market with high growth potential. Increasing awareness about personalized medicines amongst patients is further anticipated to boost adoption of cancer biomarkers.
Protein Labeling Market - The global protein labeling market size is expected to reach USD 4.11 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.6% from 2022 to 2030. The study of Post-translational Modification (PTM) of proteins has gained immense popularity in cell biology and disease treatment and prevention. The introduction of effective quantification methods of protein expression with the use of tagging strategies, such as iodoTMTzero Label Reagent that detects nitrosylation, has driven an efficient determination of PTMs. Therefore, a rise in PTM-related studies is driving the market. The emergence of novel techniques and the launch of improved products are expected to positively influence market growth.

Browse through Grand View Research's Biotechnology Industry Research Reports.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Grand View Compass | Astra ESG Solutions
Follow Us: LinkedIn | Twitter